North America Intracranial Aneurysm Market Size, Share & Trends Analysis Report By End-use (Hospitals, Clinics, and Others), By Type (Endovascular Coiling, Flow Diverters, Surgical Clipping, and Others), By Country and Growth Forecast, 2023 - 2030

The North America Intracranial Aneurysm Market would witness market growth of 7.8% CAGR during the forecast period (2023-2030).

In the dynamic landscape of neurological healthcare, the market is a pivotal arena where innovation, research, and patient care converge. These aneurysms, characterized by abnormal dilations in cerebral arteries, represent a formidable challenge due to their potential for catastrophic rupture and devastating neurological consequences. Against this backdrop, the market emerges as a multifaceted ecosystem encompassing a spectrum of stakeholders, from pioneering neurosurgeons and interventional radiologists to visionary researchers and dedicated patient advocates.

Aneurysms occur when the arterial wall is weakening or thinning in the brain’s blood vessels. This weakness can be congenital or acquired and may result from genetic factors, structural abnormalities, inflammation, infection, trauma, or degenerative changes in the blood vessel walls. Neurosurgical techniques are crucial in managing these aneurysms within the broader market. These techniques encompass a variety of surgical procedures aimed at treating, preventing, or stabilizing these aneurysms to mitigate the risk of rupture and associated neurological complications.

Brain blood vessel damage caused by the compounds in cigarette smoke can eventually result in the development of aneurysms and a gradual deterioration of cerebral blood vessels. As per the Canadian Government’s Canadian Tobacco and Nicotine Survey (CTNS), 12% of Canadians aged 25 and older were smokers in 2022. 11% of females and 14% of males are smokers. High smoking rates in Canada can indeed increase the demand for services and treatments related to these aneurysms, thereby contributing to the growth of the market in Canada. Furthermore, government initiatives and policies play a crucial role in shaping the landscape of the market in Mexico. By investing in healthcare infrastructure, promoting public awareness, subsidizing healthcare services, supporting innovation, expanding insurance coverage, and facilitating research, governments can foster an environment conducive to the growth of the market and the improvement of patient care. In conclusion, the rising smoking rates and growing government initiatives in the region are driving the growth of the market.

The US market dominated the North America Intracranial Aneurysm Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $511.3 Million by 2030. The Canada market is experiencing a CAGR of 10.2% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 9.3% during (2023 - 2030).

Based on End-use, the market is segmented into Hospitals, Clinics, and Others. Based on Type, the market is segmented into Endovascular Coiling, Flow Diverters, Surgical Clipping, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Medtronic PLC
• Stryker Corporation
• MicroPort Scientific Corporation
• Johnson & Johnson
• MicroVention, Inc. (Terumo Corporation)
• B.Braun Melsungen AG
• Integra LifeSciences Holdings Corporation
• Delta Surgical
• Penumbra, Inc.

Market Report Segmentation

By End-use

• Hospitals
• Clinics
• Others

By Type

• Endovascular Coiling
• Flow Diverters
• Surgical Clipping
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America